Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > 876K shares traded in one trade on July 27, 2023

<< Previous

Bullboard Posts

Next >>

Comment by jimsenioron Jul 31, 2023 12:41pm

211 Views

Post# 35564998

RE:RE:RE:RE:RE:876K shares traded in one trade on July 27, 2023

@Noteable. You are right. What I was saying to myself as I usually am posting for myself was that I need to find my sense of humour to deal with the outrageous story that is ONC/Y.

It does appear to be the keystone cops running the show, but I still think they are very close to something special, and have just decided to laugh at myself mostly and it seems to work.

I am waiting for a large settlement from an unrelated matter, and I do admit I am thankful it is late in coming.

Still, I believe we are very close.

We deserve some luck, and so do a few others. Cheers

<< Previous

Bullboard Posts

Next >>

Silvercorp to expand into Ecuador with C$200M Adventus acquisition